Table 2.
Hot Flash Score During the First Year of Tamoxifen Treatment
Time, Months | Score by Treatment Group
|
P* | |||||||
---|---|---|---|---|---|---|---|---|---|
Overall
|
Premenopausal
|
Perimenopausal
|
Postmenopausal
|
||||||
No. | Mean ± SE | No. | Mean ± SE | No. | Mean ± SE | No. | Mean ± SE | ||
Baseline† | 286 | 20.9 ± 2.1 | 94 | 13.9 ± 2.9 | 36 | 22.7 ± 4.9 | 156 | 24.7 ± 3.2 | 0.02 |
1‡ | 250 | 32.5 ± 3.1 | 80 | 30.2 ± 6.3 | 30 | 32.0 ± 7.9 | 139 | 34.0 ± 3.9 | 0.58 |
4§ | 238 | 32.5 ± 3.4 | 77 | 27.5 ± 5.5 | 26 | 52.2 ± 10.7 | 134 | 38.9 ± 4.8 | 0.14 |
8§ | 213 | 37.6 ± 3.8 | 65 | 30.0 ± 6.7 | 23 | 48.0 ± 9.5 | 124 | 39.4 ± 5.1 | 0.27 |
12§ | 212 | 37.9 ± 4.4 | 67 | 36.2 ± 10.3 | 21 | 45.9 ± 11.1 | 123 | 37.3 ± 4.8 | 0.90 |
Abbreviation: SE, standard error.
Comparison of premenopausal v postmenopausal patients.
All patients who returned their hot flash diaries provided information regarding their menopausal status.
One participant who did not provide information regarding her menopausal status returned hot flash diaries on months 1, 4, 8, and 12.
Comparison among different menopausal status stages.